Cargando…

Continuing fingolimod after development of macular edema: A case report

Detalles Bibliográficos
Autores principales:	Li, Vivien, Kane, Jack, Chan, Helen H.L., Hall, Anthony J., Butzkueven, Helmut
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2014
Materias:	Clinical/Scientific Notes
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4202669/ https://www.ncbi.nlm.nih.gov/pubmed/25340066 http://dx.doi.org/10.1212/NXI.0000000000000013

Ejemplares similares

Acute onset of fingolimod-associated macular edema
por: Soliman, Mohamed Kamel, et al.
Publicado: (2016)

Combination of teriflunomide and interferon as follow-up therapy after fingolimod-associated PML
por: Fischer-Barnicol, Bettina, et al.
Publicado: (2020)

Intracerebral lymphoproliferative disorder in an MS patient treated with fingolimod
por: de Jong, Brigit A., et al.
Publicado: (2018)

Dramatic rebounds of MS during pregnancy following fingolimod withdrawal
por: Novi, Giovanni, et al.
Publicado: (2017)

Disseminated Histoplasmosis in a Patient With Multiple Sclerosis Treated With Fingolimod
por: Abrahamowicz, Aleksandra A., et al.
Publicado: (2021)

Cytomegalovirus Encephalitis Under Fingolimod Mimicking Progressive Multifocal Leukoencephalopathy?
por: Oel, Dierk, et al.
Publicado: (2021)

Diagnosis and Management of Fingolimod-Associated Macular Edema
por: Wang, Chunjiang, et al.
Publicado: (2022)

COVID-19 infection in a patient with multiple sclerosis treated with fingolimod
por: Barzegar, Mahdi, et al.
Publicado: (2020)

HSV-2–related hemophagocytic lymphohistiocytosis in a fingolimod-treated patient with MS
por: Ikumi, Kazuhiro, et al.
Publicado: (2016)

Tumefactive demyelination with a transient appearance of oligoclonal bands in MS under fingolimod
por: Okada, Kazumasa, et al.
Publicado: (2018)

Fingolimod-associated severe bilateral cystoid macular edema
por: Fukuoka, Hideki, et al.
Publicado: (2022)

Fingolimod-Associated Macular Edema in the Treatment of Multiple Sclerosis
por: Khan, Asma A, et al.
Publicado: (2023)

Longitudinal T-Cell Responses After a Third SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis on Ocrelizumab or Fingolimod
por: Palomares Cabeza, Virginia, et al.
Publicado: (2022)

Avidity of vaccine-induced influenza IgG fails to increase in fingolimod-treated patients with MS
por: Mehling, Matthias, et al.
Publicado: (2014)

Fingolimod Associated Bilateral Cystoid Macular Edema—Wait and See?
por: Pul, Refik, et al.
Publicado: (2016)

Retraction Note to: Pharmacological agents in development for diabetic macular edema
por: Sadiq, Mohammad Ali, et al.
Publicado: (2020)

Fingolimod-associated macular edema controlled with nepafenac non-steroidal anti-inflammatory opthalmologic applications
por: Husmann, Rachel, et al.
Publicado: (2020)

Evaluation of pregnancy outcomes in patients with multiple sclerosis after fingolimod exposure
por: Geissbühler, Yvonne, et al.
Publicado: (2018)

Improvement of macular edema without discontinuation of fingolimod in a patient with multiple sclerosis: A case report
por: Akiyama, Hisanao, et al.
Publicado: (2016)

Incidence of uveitis and macular edema among patients taking fingolimod 0.5 mg for multiple sclerosis
por: Sonne, Scott Joseph, et al.
Publicado: (2020)

The effects of intravitreal adalimumab injection on pseudophakic macular edema
por: Farvardin, Mohsen, et al.
Publicado: (2020)

Refractory chronic spontaneous urticaria after the use of alemtuzumab in multiple sclerosis
por: Hu, Hannah, et al.
Publicado: (2020)

Incidence of Cystoid Macular Edema After Descemet Membrane Endothelial Keratoplasty
por: Kocaba, Viridiana, et al.
Publicado: (2018)

Case of alemtuzumab-related alopecia areata management in MS
por: Chan, Jillian K., et al.
Publicado: (2018)

COMBINED TREATMENT WITH BEVACIZUMAB AND TRIAMCINOLONE ACETONIDE FOR MACULAR EDEMA DUE TO RETINAL VEIN OCCLUSION
por: Vinković, Maja, et al.
Publicado: (2020)

Risk Factors for Cystoid Macular Edema After Descemet Membrane Endothelial Keratoplasty
por: Inoda, Satoru, et al.
Publicado: (2019)

Macular Edema after Gabapentin
por: Kim, Ju Young, et al.
Publicado: (2016)

SPG7 mutations are a common cause of undiagnosed ataxia
por: Pfeffer, Gerald, et al.
Publicado: (2015)

Multiple Sclerosis Relapses Following Cessation of Fingolimod
por: Malpas, Charles B., et al.
Publicado: (2022)

VISUAL OUTCOMES IN PATIENTS WITH DIABETIC MACULAR EDEMA TREATED WITH DEXAMETHASONE IMPLANT IN ROUTINE CLINICAL PRACTICE
por: Urbančič, Mojca, et al.
Publicado: (2021)

Incomplete Susac syndrome exacerbated after natalizumab
por: Zhovtis Ryerson, Lana, et al.
Publicado: (2015)

Disease exacerbation after rituximab induction in neuromyelitis optica
por: Perumal, Jai S., et al.
Publicado: (2015)

Familial Brain Calcifications With Leukoencephalopathy: A Novel PDGFB Variant
por: Shen, Jack, et al.
Publicado: (2022)

Early cervical myelitis after human papilloma virus vaccination
por: Fernández-Fournier, Mireya, et al.
Publicado: (2014)

Microscopic polyangiitis after alemtuzumab treatment in relapsing-remitting MS
por: Sauer, Eva-Maria, et al.
Publicado: (2018)

Vanishing spinal cord after varicella-zoster virus myelitis
por: Sepúlveda, María, et al.
Publicado: (2017)

Drug reaction with eosinophilia and systemic symptoms after daclizumab therapy in MS
por: Scheibe, Franziska, et al.
Publicado: (2018)

Acute disseminated encephalomyelitis after SARS-CoV-2 infection
por: Novi, Giovanni, et al.
Publicado: (2020)

When is macular edema not macular edema? An update on macular telangiectasia type 2
por: Wu, Lihteh
Publicado: (2015)

Severe exacerbation of relapsing-remitting multiple sclerosis after G-CSF therapy
por: Rust, Heiko, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_q46ntbcph6fpk2tiv2ailfqdp8